InnovAge (NASDAQ:INNV – Get Free Report) and SeaStar Medical (NASDAQ:ICU – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.
Earnings & Valuation
This table compares InnovAge and SeaStar Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InnovAge | $763.85 million | 0.70 | -$21.34 million | ($0.23) | -17.22 |
| SeaStar Medical | $140,000.00 | 169.06 | -$24.83 million | ($2.62) | -0.32 |
Risk & Volatility
InnovAge has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.04, meaning that its share price is 204% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for InnovAge and SeaStar Medical, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InnovAge | 1 | 1 | 0 | 0 | 1.50 |
| SeaStar Medical | 0 | 0 | 0 | 0 | 0.00 |
InnovAge currently has a consensus target price of $5.00, indicating a potential upside of 26.26%. Given InnovAge’s stronger consensus rating and higher possible upside, research analysts clearly believe InnovAge is more favorable than SeaStar Medical.
Profitability
This table compares InnovAge and SeaStar Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InnovAge | -3.75% | -11.91% | -5.85% |
| SeaStar Medical | -1,915.27% | N/A | -232.65% |
Institutional and Insider Ownership
12.3% of InnovAge shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 1.4% of InnovAge shares are held by company insiders. Comparatively, 1.3% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
InnovAge beats SeaStar Medical on 10 of the 13 factors compared between the two stocks.
About InnovAge
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.
